Therefore, blocking CD24 or Siglec-10 with monoclonal antibodies enhances the ability of macrophages to phagocytose tumor cells and inhibit tumor growth; this approach may be useful for patients who are unresponsive to meditators of the PD-1/PD-L1 pathway. This evidence concerns the gene CD274 and neoplasm.